Brentuximab vedotin for treating relapsed or refractory CD30-positive cutaneous T-cell lymphoma (17/56/12)

Authors
Publication date
25 October 2018
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    University of Liverpool Repository

    redirect
    oaioai:livrepository.liverpool.ac...
    Last time updated on 04/09/2020